Merck

AP101P

Sigma-Aldrich

Rabbit Anti-Human IgG Antibody, HRP conjugate

Chemicon®, from rabbit

ログインto View Organizational & Contract Pricing

Select a Size

eCl@ss:
32160702
NACRES:
NA.46

由来生物

rabbit

品質水準

結合体

peroxidase conjugate

抗体製品の状態

F(ab′)2 fragment of affinity isolated antibody

antibody product type

secondary antibodies

クローン

polyclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

ELISA: suitable
western blot: suitable

輸送温度

wet ice

target post-translational modification

unmodified

関連するカテゴリー

類似品目との比較

比較内容をすべて表示

相違点を表示

1 of 4

当該品目
AQ160PAQ132PAP156P
conjugate

peroxidase conjugate

conjugate

peroxidase conjugate

conjugate

peroxidase conjugate

conjugate

peroxidase conjugate

antibody form

F(ab′)2 fragment of affinity isolated antibody

antibody form

F(ab′)2 fragment of affinity isolated antibody

antibody form

F(ab′)2 fragment of affinity isolated antibody

antibody form

F(ab′)2 fragment of affinity isolated antibody

clone

polyclonal

clone

polyclonal

clone

polyclonal

clone

polyclonal

species reactivity

human

species reactivity

mouse

species reactivity

rabbit

species reactivity

rabbit

technique(s)

ELISA: suitable, western blot: suitable

technique(s)

ELISA: suitable, western blot: suitable

technique(s)

ELISA: suitable, western blot: suitable

technique(s)

ELISA: suitable, western blot: suitable

アプリケーション

Research Category
二次抗体及びコントロール抗体
Research Sub Category
全免疫グロブリン検出用二次抗体
Detect Human IgG using this Rabbit anti-Human IgG Antibody, HRP conjugate validated for use in ELISA & WB.

法的情報

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

保管分類コード

11 - Combustible Solids

WGK

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

ウェブサイトの表示では、製品番号に容量/数量が連結しています(例:T1503-25G)。確認してください 製品番号欄には製品番号のみを入力してください (: T1503).

T1503
製品番号
-
25G
容量/数量

その他の例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

以下のように入力してください 1.000309185)

ご不明な点がございましたら、お気軽にお問い合わせくださいテクニカルサービス お問い合わせ

ロット番号とバッチ番号は、製品ラベルで「Lot」または「Batch」の言葉に続いて記載されています。

Aldrich製品

  • もしTO09019TOなどのロット番号を見つけた場合は、最初の2文字を除いたロット番号09019TOを入力します。

  • もし05427ES-021などの充てんコード付きロット番号を見つけた場合は、充てんコードの-021を除いたロット番号05427ESを入力します。

  • もしSTBB0728K9などの充てんコード付きロット番号を見つけた場合は、充てんコードのK9を除いたロット番号STBB0728を入力します。

お探しのものが見つかりませんか?

オンラインでCOAを入手できない場合があります。検索してもCOAが見つからない場合は、リクエストできます。

COAをリクエストする

Kasopefoluwa Y Oguntuyo et al.
medRxiv : the preprint server for health sciences (2020-08-21)
The global COVID-19 pandemic has mobilized efforts to develop vaccines and antibody-based therapeutics, including convalescent plasma therapy, that inhibit viral entry by inducing or transferring neutralizing antibodies (nAbs) against the SARS-CoV-2 spike glycoprotein (CoV2-S). However, rigorous efficacy testing requires extensive
Bibek Parajuli et al.
The Biochemical journal, 475(5), 931-957 (2018-01-19)
We previously reported a first-generation recombinant DAVEI construct, a dual action virus entry inhibitor composed of cyanovirin-N (CVN) fused to a membrane proximal external region or its derivative peptide Trp3. DAVEI exhibits potent and irreversible inactivation of HIV-1 (human immunodeficiency
Kasopefoluwa Y Oguntuyo et al.
mBio, 12(1) (2021-02-18)
The global coronavirus disease 2019 (COVID-19) pandemic has mobilized efforts to develop vaccines and antibody-based therapeutics, including convalescent-phase plasma therapy, that inhibit viral entry by inducing or transferring neutralizing antibodies (nAbs) against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Bibek Parajuli et al.
Biochemistry, 55(44), 6100-6114 (2016-10-13)
We recently reported the discovery of a recombinant chimera, denoted DAVEI (dual-acting virucidal entry inhibitor), which is able to selectively cause specific and potent lytic inactivation of both pseudotyped and fully infectious human immunodeficiency virus (HIV-1) virions. The chimera is
Antigen discovery by bioinformatics analysis and peptide microarray for the diagnosis of cystic echinococcosis.
Batisti Biffignandi, et al.
PLoS Neglected Tropical Diseases, 17, e0011210-e0011210 (2023)

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

テクニカルサービス連絡先